May 13, 2021
Business News

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Emergent BioSolutions Inc. (EBS) on Behalf of Investors


LOS ANGELES–()–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Emergent BioSolutions Inc. (“Emergent” or the “Company”) (NYSE: EBS) investors concerning the Company’s possible violations of the federal securities laws.

If you suffered a loss on your Emergent investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/emergent-biosolutions-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at



Click here to view the original article.

Related Posts

You might also like ...

Swimlane y Elastic unen fuerzas para ofrecer una estructura extensible dirigida a equipos de operaciones de seguridad
AON Splash Image
PS Business Parks, Inc. Announces Departure of John W. Petersen, Executive Vice President and Chief Operating Officer
AbCellera Reports Q1 2021 Business Results